drugset / Trial / NCT00832377

COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED)

NCT00832377

Phase 2 Completed 37 enrolled Merck Sharp & Dohme LLC
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A study to evaluate the effect of the 12-week treatment with timolol/dorzolamide combination eyedrops (COSOPT) on decrease in intraocular pressure (IOP) at 2 hours after the study drug administration

Timeline

Start
2009-04-24
Primary completion
2010-03-12
Completion
2010-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzolamide Small molecule Other
Subject Timolol Other / unclassified Other

Indications